| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.81.2.137 |
| P698 | PubMed publication ID | 9242174 |
| P2093 | author name string | Schneider MD | |
| MacLellan WR | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| cell death | Q2383867 | ||
| P304 | page(s) | 137-144 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Death by design. Programmed cell death in cardiovascular biology and disease | |
| P478 | volume | 81 |
| Q92591248 | 25-Hydroxycholesterol protects against myocardial ischemia-reperfusion injury via inhibiting PARP activity |
| Q35762460 | A decade of discoveries in cardiac biology |
| Q24535352 | Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. |
| Q36004798 | Adiponectin protects against the development of systolic dysfunction following myocardial infarction. |
| Q39870130 | Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. |
| Q50508773 | Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes. |
| Q44679492 | Antagonism of endothelin-1 inhibits hypoxia-induced apoptosis in cardiomyocytes |
| Q37774361 | Antiapoptotic potential of herbal drugs in cardiovascular disorders: an overview |
| Q35596965 | Apoptosis and oxidants in the heart |
| Q74732633 | Apoptosis in heart failure |
| Q74842139 | Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study |
| Q77802842 | Apoptosis in the failing heart |
| Q34473433 | Apoptosis in the ischemic reperfused myocardium |
| Q28594658 | Apoptosis in the pattern formation of the ventricular wall during mouse heart organogenesis |
| Q34078534 | Apoptosis: mechanisms and clinical implications |
| Q37263689 | Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling |
| Q39578214 | Association between the severity of heart failure and the susceptibility of myocytes to apoptosis in patients with idiopathic dilated cardiomyopathy |
| Q42186548 | Autophagy in the myocardium: Dying for survival? |
| Q44438374 | Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice |
| Q77424868 | Bcl-2/Bax protein expression in heart, slow-twitch and fast-twitch muscles in young rats growing under chronic hypoxia conditions |
| Q42332443 | Beta blockers in heart failure haemodynamics, clinical effects and modes of action |
| Q37644143 | Blockage of transient receptor potential vanilloid 4 alleviates myocardial ischemia/reperfusion injury in mice. |
| Q34687837 | Cardiac apoptosis: from organ failure to allograft rejection. |
| Q28263599 | Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells |
| Q64120333 | Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice |
| Q78181096 | Cardiomyocyte apoptosis with enhanced expression of P53 and Bax in right ventricle after pulmonary arterial banding |
| Q34393925 | Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways |
| Q34247662 | Cardioprotective effect of ammonium glycyrrhizinate against doxorubicin-induced cardiomyopathy in experimental animals |
| Q43212275 | Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats |
| Q44363772 | Caveolar compartmentation of caspase-3 in cardiac endothelial cells |
| Q57912727 | Cell death effects of resin-based dental material compounds and mercurials in human gingival fibroblasts |
| Q36287930 | Cell death, tissue hypoxia and the progression of heart failure |
| Q43558014 | Characterization of ultrastructure and its relation with DNA fragmentation in Fas-induced apoptosis of cultured cardiac myocytes |
| Q57298849 | Chronic right ventricular pressure overload results in a hyperplastic rather than a hypertrophic myocardial response |
| Q24804131 | Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure |
| Q34243966 | Clinical implications of physiological changes in the aging heart |
| Q34587120 | Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway |
| Q36788813 | Computational modeling of acute myocardial infarction |
| Q36310580 | Conditional lineage ablation to model human diseases |
| Q35745355 | Control of apoptosis during angiogenesis by survivin expression in endothelial cells |
| Q37016365 | Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury |
| Q37406242 | Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction. |
| Q36732005 | Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets |
| Q44860124 | Delayed myocardial preconditioning by alpha1-adrenoceptors involves inhibition of apoptosis |
| Q43185707 | Dental pulp-derived stem cell conditioned medium reduces cardiac injury following ischemia-reperfusion |
| Q35546856 | Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? |
| Q34532248 | Development of left ventricular diastolic dysfunction with preservation of ejection fraction during progression of infant right ventricular hypertrophy |
| Q49449899 | Does growth differentiation factor 11 protect against myocardial ischaemia/reperfusion injury? A hypothesis |
| Q25257418 | Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury |
| Q44007391 | Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention. |
| Q33787713 | Effects of hypothalamic paraventricular nuclei on apoptosis and proliferation of gastric mucosal cells induced by ischemia/reperfusion in rats |
| Q44384824 | Effects of long-term selenium deficiency on glutathione peroxidase and thioredoxin reductase activities and expressions in rat aorta |
| Q53701593 | Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice. |
| Q52046408 | Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. |
| Q46410537 | Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells |
| Q39737479 | Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload |
| Q34490969 | Gene therapy and pharmaceutical modulation of apoptosis |
| Q36074350 | Glycyrrhetinic acid protects H9c2 cells from oxygen glucose deprivation-induced injury through the PI3K/AKt signaling pathway |
| Q42821467 | Gone fission…: diverse consequences of cardiac Drp1 deficiency |
| Q44654247 | Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro |
| Q38010378 | High molecular weight calmodulin-binding protein: 20 years onwards-a potential therapeutic calpain inhibitor |
| Q73946165 | Histaminergic effect on apoptosis of rat small intestinal mucosa after ischemia-reperfusion |
| Q54455328 | Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt. |
| Q33853515 | Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. |
| Q28579974 | Hypoxia-reoxygenation-induced apoptosis in cultured neonatal rat cardiomyocyets and the protective effect of prostaglandin E |
| Q30874354 | Identification of TNF-alpha inhibitors from a split-pool library based on a tyrosine-proline peptidomimetic scaffold |
| Q44026937 | Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis |
| Q28580962 | Insulin-like growth factor binding protein-3 mediates serum starvation- and doxorubicin-induced apoptosis in H9c2 cardiac cells |
| Q46917541 | Interrelations between oxidative stress and calcineurin in the attenuation of cardiac apoptosis by eugenol |
| Q83333021 | Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice |
| Q24290762 | KIAP, a novel member of the inhibitor of apoptosis protein family |
| Q35754496 | Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice |
| Q34289663 | Life and death of a cardiac myocyte: principles of cellular biology |
| Q38793557 | MAPK1 up-regulates the expression of MALAT1 to promote the proliferation of cardiomyocytes through PI3K/AKT signaling pathway |
| Q44160668 | MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner |
| Q38496407 | Methanolic extract of onion (Allium cepa) attenuates ischemia/hypoxia-induced apoptosis in cardiomyocytes via antioxidant effect |
| Q35056906 | Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway |
| Q44020107 | Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy |
| Q36430856 | Morphological aspects of apoptosis in heart diseases |
| Q38354996 | Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro |
| Q73582644 | Myocardial apoptosis after cardioplegic arrest in the neonatal lamb |
| Q35213048 | Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. |
| Q36221185 | Myocyte proliferation in end-stage cardiac failure in humans |
| Q53084627 | NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2. |
| Q39032488 | NecroX-5 suppresses sodium nitroprusside-induced cardiac cell death through inhibition of JNK and caspase-3 activation |
| Q42463523 | New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats |
| Q73450838 | Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes |
| Q46402883 | Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress |
| Q54264480 | Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury. |
| Q46775223 | PKCbeta modulates ischemia-reperfusion injury in the heart |
| Q85236027 | Pre-treatment with α-tocopherol and Terminalia arjuna ameliorates, pro-inflammatory cytokines, cardiac and apoptotic markers in myocardial infracted rats |
| Q35998368 | Prenatal hypoxia and cardiac programming |
| Q43561414 | Prevention of deleterious effects of reperfusion injury using one-week high-dose allopurinol |
| Q33230870 | Protective effect of KR-31378 on oxidative stress in cardiac myocytes |
| Q41880497 | Protective effect of ginsenoside Rg1 on lidocaine-induced apoptosis |
| Q38519413 | Quercetin protects the hydrogen peroxide-induced apoptosis via inhibition of mitochondrial dysfuntion in H9c2 cardiomyoblast cells |
| Q33559727 | RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. |
| Q33927958 | Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors |
| Q73209466 | Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors |
| Q52941550 | Regulation of caspase 3 and Fas in pressure overload-induced left ventricular dysfunction. |
| Q74536125 | Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia |
| Q31965325 | Role of tensile stress and strain in the induction of cell death in experimental vein grafts |
| Q47074042 | SNX13 reduction mediates heart failure through degradative sorting of apoptosis repressor with caspase recruitment domain |
| Q34581832 | Safflor yellow A protects neonatal rat cardiomyocytes against anoxia/reoxygenation injury in vitro |
| Q38081113 | Sex differences in myocardial metabolism and cardiac function: an emerging concept |
| Q35580331 | Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning |
| Q63363542 | Sodium nitroprusside induces autophagic cell death in glutathione-depleted osteoblasts |
| Q40856140 | Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stewss-induced inhibition of JNK dephosphorylation |
| Q64979026 | TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. |
| Q45004611 | Tadalafil prevents acute heart failure with reduced ejection fraction in mice |
| Q50515033 | Thapsigargin enhances camptothecin-induced apoptosis in cardiomyocytes. |
| Q61912834 | The Multiple Actions of the Insulin-Like Growth Factor-I Signaling in the Myocardium |
| Q93144193 | The Role of Autophagy and Death Pathways in Dose-dependent Isoproterenolinduced Cardiotoxicity |
| Q40452360 | The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions? |
| Q34027423 | The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure |
| Q34060768 | The multiple actions of angiotensin II in atherosclerosis |
| Q53213949 | The role of curcumin on intestinal oxidative stress, cell proliferation and apoptosis after ischemia/reperfusion injury in rats. |
| Q48369471 | The water extract of Omija protects H9c2 cardiomyoblast cells from hydrogen peroxide through prevention of mitochondrial dysfunction and activation of caspases pathway |
| Q35820226 | Total saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway. |
| Q64062178 | Use of Multifactorial Treatments to Address the Challenge of Translating Experimental Myocardial Infarct Reduction Strategies |
| Q52535812 | [Cell death in inflammatory heart muscle diseases--apoptosis or necrosis?]. |
| Q28566908 | iNOS enhances rat intestinal apoptosis after ischemia-reperfusion |
| Q53585472 | sCD30, interleukin-1beta-converting enzyme and anti-Annexin V autoantibodies concentrations in heart transplant recipients. |
Search more.